An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Study ID
NCT04688411
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - 21 Years
Healthy Volunteers
Not accepted

Interventions

  • MED-Go App — BEHAVIORAL
    A novel multifunctional mobile app (MED-Go) to improve adherence to hydroxyurea in patients with sickle cell disease

Study Details

The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and improve health outcomes in AYA with SCD.

Key Dates

Start date
Sep 28, 2020
Status verified
Nov 2024
Primary completion
Feb 1, 2025
Completion
Feb 1, 2025

Study Design

Enrollment
40 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Other: MED-Go app Intervention
    Participants will use MED-Go app intervention for a total of 12 weeks
  • No Intervention: Control Arm
    Standard of care

Primary Outcome Measure

Percentage of patients achieving feasibility criteria of using the MED-Go app [ Time Frame: 12 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Ann & Robert H Lurie Children's Hospital of ChicagoChicagoIllinois60611
Sherif M. Badawy, MD, MS
[email protected]
312-227-4836
Savannah Winkler, BS
[email protected]
(312) 227-4807
Sherif M. Badawy, MD, MS (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chicago, IL

By condition
Sickle cell disease
By research site
Ann & Robert H Lurie Children's Hospital of Chicago· Chicago, IL

Related Studies